ruxolitinib

CD274 molecule ; Homo sapiens







8 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35151642 ATRA promotes PD-L1 expression to control gastric cancer immune surveillance. 2022 Apr 5 2
2 33341940 Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand-1 (PD-L1) expression and increases anti-tumour effects of T cells in multiple myeloma. 2021 Feb 3
3 33965175 Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells. 2021 May 1
4 34422627 CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways. 2021 1
5 34733993 CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway. 2021 Sep 1
6 31867003 JAK Inhibitors and Oxidative Stress Control. 2019 1
7 29933930 JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer. 2018 Oct 2
8 30035369 Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers. 2018 Nov 1